Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients
Celsa A. Spina, Jenny L. Anderson, Nancie M. Archin, et al.
PLoS Pathogens (2013) Vol. 9, Iss. 12, pp. e1003834-e1003834
Open Access | Times Cited: 400

Showing 1-25 of 400 citing articles:

Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H Elliott, Fiona Wightman, Ajantha Solomon, et al.
PLoS Pathogens (2014) Vol. 10, Iss. 11, pp. e1004473-e1004473
Open Access | Times Cited: 485
International AIDS Society global scientific strategy: towards an HIV cure 2016
Steven G. Deeks, Sharon R. Lewin, Anna Laura Ross, et al.
Nature Medicine (2016) Vol. 22, Iss. 8, pp. 839-850
Open Access | Times Cited: 403
Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations
Gregory M. Laird, C. Korin Bullen, Daniel I. S. Rosenbloom, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 5, pp. 1901-1912
Open Access | Times Cited: 377
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Nancie M. Archin, Julia Marsh Sung, Carolina Garrido, et al.
Nature Reviews Microbiology (2014) Vol. 12, Iss. 11, pp. 750-764
Open Access | Times Cited: 270
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
Gilles Darcis, Anna Kula, Sophie Bouchat, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 7, pp. e1005063-e1005063
Open Access | Times Cited: 263
HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy
Yonatan Ganor, Fernando Real, Alexis Sennepin, et al.
Nature Microbiology (2019) Vol. 4, Iss. 4, pp. 633-644
Closed Access | Times Cited: 262
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals
Francesco A. Procopio, Rémi Fromentin, Deanna A. Kulpa, et al.
EBioMedicine (2015) Vol. 2, Iss. 8, pp. 874-883
Open Access | Times Cited: 255
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy
Jenna B. Honeycutt, William O. Thayer, Caroline Baker, et al.
Nature Medicine (2017) Vol. 23, Iss. 5, pp. 638-643
Open Access | Times Cited: 255
Latency reversal and viral clearance to cure HIV-1
David M. Margolis, J. Víctor García, Daria J. Hazuda, et al.
Science (2016) Vol. 353, Iss. 6297
Open Access | Times Cited: 222
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
Weijun Zhu, Rongyue Lei, Yann Le Duff, et al.
Retrovirology (2015) Vol. 12, Iss. 1
Open Access | Times Cited: 210
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
Guillaume Mousseau, Cari F. Kessing, Rémi Fromentin, et al.
mBio (2015) Vol. 6, Iss. 4
Open Access | Times Cited: 207
Understanding HIV Latency: The Road to an HIV Cure
Matthew S. Dahabieh, Emilie Battivelli, Eric Verdin
Annual Review of Medicine (2015) Vol. 66, Iss. 1, pp. 407-421
Open Access | Times Cited: 203
The mTOR Complex Controls HIV Latency
Emilie Besnard, Shweta Hakre, Martin Kampmann, et al.
Cell Host & Microbe (2016) Vol. 20, Iss. 6, pp. 785-797
Open Access | Times Cited: 183
Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals
Amy E. Baxter, Julia Niessl, Rémi Fromentin, et al.
Cell Host & Microbe (2016) Vol. 20, Iss. 3, pp. 368-380
Open Access | Times Cited: 182
Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation
Guochun Jiang, Érica Araújo Mendes, Philipp Kaiser, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 7, pp. e1005066-e1005066
Open Access | Times Cited: 181
Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
Szu-Han Huang, Yanqin Ren, Allison S. Thomas, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 2, pp. 876-889
Open Access | Times Cited: 173
Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells
Emilie Battivelli, Matthew S. Dahabieh, Mohamed Abdel‐Mohsen, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 166
Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
Amina Aït-Ammar, Anna Kula, Gilles Darcis, et al.
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 151
Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations
Judith Grau-Expósito, Laura Luque-Ballesteros, Jordi Navarro, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 8, pp. e1007991-e1007991
Open Access | Times Cited: 146
Position effects influence HIV latency reversal
Heng‐Chang Chen, Javier P. Martínez, Eduard Zorita, et al.
Nature Structural & Molecular Biology (2016) Vol. 24, Iss. 1, pp. 47-54
Open Access | Times Cited: 158
Novel Latency Reversal Agents for HIV-1 Cure
Adam M. Spivak, Vicente Planelles
Annual Review of Medicine (2017) Vol. 69, Iss. 1, pp. 421-436
Open Access | Times Cited: 152
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Angela Tsai, Alivelu Irrinki, Jasmine Kaur, et al.
Journal of Virology (2017) Vol. 91, Iss. 8
Open Access | Times Cited: 150
HIV “shock and kill” therapy: In need of revision
Erik Abner, Albert Jordan
Antiviral Research (2019) Vol. 166, pp. 19-34
Closed Access | Times Cited: 144
HIV Latency: Should We Shock or Lock?
Gilles Darcis, Benoît Van Driessche, Carine Van Lint
Trends in Immunology (2017) Vol. 38, Iss. 3, pp. 217-228
Closed Access | Times Cited: 137
Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation
Lillian B. Cohn, Israel Tojal da Silva, Renan Valieris, et al.
Nature Medicine (2018) Vol. 24, Iss. 5, pp. 604-609
Open Access | Times Cited: 133
Page 1 - Next Page

Scroll to top